Don Dizon

Summary

Affiliation: Women and Infants' Hospital
Country: USA

Publications

  1. Dizon D, Damstrup L, Finkler N, Lassen U, CELANO P, Glasspool R, et al. Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer. Int J Gynecol Cancer. 2012;22:979-86 pubmed publisher
    ..The addition of belinostat to this platinum-based regimen represents a novel approach to EOC therapy and warrants further exploration. ..
  2. Dizon D. Quality of life after breast cancer: survivorship and sexuality. Breast J. 2009;15:500-4 pubmed publisher
    ..This report will focus on these four issues highlighting information for the treating oncologist which can assist in the evaluation, counseling, and treatment for their patients. ..
  3. Dizon D, Blessing J, McMeekin D, Sharma S, Disilvestro P, Alvarez R. Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-P. J Clin Oncol. 2009;27:3104-8 pubmed publisher
    ..CONCLUSION In a cohort of women with advanced or recurrent endometrial cancer who were previously treated with paclitaxel, ixabepilone showed modest activity of limited duration as a second-line agent. ..